Rasmus Sejersten Ripa

Summary

Affiliation: University of Copenhagen
Country: Denmark

Publications

  1. ncbi Granulocyte-colony stimulating factor therapy to induce neovascularization in ischemic heart disease
    Rasmus Sejersten Ripa
    Department of Cardiology, Rigshospitalet, Copenhagen, Denmark
    Dan Med J 59:B4411. 2012
  2. ncbi Plasma YKL-40 and recovery of left ventricular function after acute myocardial infarction
    Anne Hedegaard
    Department of Cardiology, The Heart Centre, Rigshospitalet, Copenhagen University Hospital and University of Copenhagen, Faculty of Health Sciences, Copenhagen, Denmark
    Scand J Clin Lab Invest 70:80-6. 2010
  3. ncbi Short- and long-term changes in myocardial function, morphology, edema, and infarct mass after ST-segment elevation myocardial infarction evaluated by serial magnetic resonance imaging
    Rasmus Sejersten Ripa
    Department of Cardiology, The Heart Centre, University Hospital Rigshospitalet, Copenhagen, Denmark
    Am Heart J 154:929-36. 2007
  4. ncbi Timing of granulocyte-colony stimulating factor treatment after acute myocardial infarction and recovery of left ventricular function: results from the STEMMI trial
    Mikkel Overgaard
    Department of Cardiology, The Heart Centre, Rigshospitalet, Copenhagen University Hospital, Denmark
    Int J Cardiol 140:351-5. 2010
  5. ncbi The influence of genotype on vascular endothelial growth factor and regulation of myocardial collateral blood flow in patients with acute and chronic coronary heart disease
    Rasmus Sejersten Ripa
    Department of Cardiology, The Heart Centre, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    Scand J Clin Lab Invest 69:722-8. 2009
  6. ncbi YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery disease
    Yongzhong Wang
    Medical Department B, Cardiac Catheterization Laboratory, The Heart Centre, Rigshospitalet, University Hospital Copenhagen, Faculty of Health Sciences, University of Copenhagen, Denmark
    Scand Cardiovasc J 42:295-302. 2008
  7. ncbi Bone marrow derived mesenchymal cell mobilization by granulocyte-colony stimulating factor after acute myocardial infarction: results from the Stem Cells in Myocardial Infarction (STEMMI) trial
    Rasmus Sejersten Ripa
    Department of Cardiology, The Heart Centre, University Hospital Rigshospitalet, DK 2100 Copenhagen Ø, Denmark
    Circulation 116:I24-30. 2007
  8. ncbi Circulating angiogenic cytokines and stem cells in patients with severe chronic ischemic heart disease--indicators of myocardial ischemic burden?
    Rasmus Sejersten Ripa
    Cardiac Catheterization Laboratory, University Hospital Rigshospitalet, Copenhagen, Denmark
    Int J Cardiol 120:181-7. 2007
  9. ncbi G-CSF therapy with mobilization of bone marrow stem cells for myocardial recovery after acute myocardial infarction--a relevant treatment?
    Rasmus Sejersten Ripa
    Department of Cardiology, The Heart Centre, Rigshospitalet, Copenhagen University Hospital, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
    Exp Hematol 36:681-6. 2008
  10. ncbi Myocardial regeneration induced by granulocyte-colony-stimulating factor mobilization of stem cells in patients with acute or chronic ischaemic heart disease: a non-invasive alternative for clinical stem cell therapy?
    Jens Kastrup
    Department of Cardiology, The Heart Centre, University Hospital Rigshospitalet, Copenhagen, Denmark
    Eur Heart J 27:2748-54. 2006

Collaborators

Detail Information

Publications11

  1. ncbi Granulocyte-colony stimulating factor therapy to induce neovascularization in ischemic heart disease
    Rasmus Sejersten Ripa
    Department of Cardiology, Rigshospitalet, Copenhagen, Denmark
    Dan Med J 59:B4411. 2012
    ..Ultimately, this will require large randomized, double-blind and placebo-controlled trials with "hard" clinical endpoints like mortality and morbidity...
  2. ncbi Plasma YKL-40 and recovery of left ventricular function after acute myocardial infarction
    Anne Hedegaard
    Department of Cardiology, The Heart Centre, Rigshospitalet, Copenhagen University Hospital and University of Copenhagen, Faculty of Health Sciences, Copenhagen, Denmark
    Scand J Clin Lab Invest 70:80-6. 2010
    ....
  3. ncbi Short- and long-term changes in myocardial function, morphology, edema, and infarct mass after ST-segment elevation myocardial infarction evaluated by serial magnetic resonance imaging
    Rasmus Sejersten Ripa
    Department of Cardiology, The Heart Centre, University Hospital Rigshospitalet, Copenhagen, Denmark
    Am Heart J 154:929-36. 2007
    ..The aim of this study was to evaluate effects of therapy for STEMI on left ventricular function and perfusion and to test the hypothesis that myocardial perfusion by MRI predicts recovery of left ventricular function...
  4. ncbi Timing of granulocyte-colony stimulating factor treatment after acute myocardial infarction and recovery of left ventricular function: results from the STEMMI trial
    Mikkel Overgaard
    Department of Cardiology, The Heart Centre, Rigshospitalet, Copenhagen University Hospital, Denmark
    Int J Cardiol 140:351-5. 2010
    ..However, recent studies suggest that timing of G-CSF therapy is crucial...
  5. ncbi The influence of genotype on vascular endothelial growth factor and regulation of myocardial collateral blood flow in patients with acute and chronic coronary heart disease
    Rasmus Sejersten Ripa
    Department of Cardiology, The Heart Centre, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    Scand J Clin Lab Invest 69:722-8. 2009
    ....
  6. ncbi YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery disease
    Yongzhong Wang
    Medical Department B, Cardiac Catheterization Laboratory, The Heart Centre, Rigshospitalet, University Hospital Copenhagen, Faculty of Health Sciences, University of Copenhagen, Denmark
    Scand Cardiovasc J 42:295-302. 2008
    ..Aim was to quantitate plasma YKL-40 in patients with ST-elevation myocardial infarction (STEMI) or stable chronic coronary artery disease (CAD), and YKL-40 gene activation in human myocardium...
  7. ncbi Bone marrow derived mesenchymal cell mobilization by granulocyte-colony stimulating factor after acute myocardial infarction: results from the Stem Cells in Myocardial Infarction (STEMMI) trial
    Rasmus Sejersten Ripa
    Department of Cardiology, The Heart Centre, University Hospital Rigshospitalet, DK 2100 Copenhagen Ø, Denmark
    Circulation 116:I24-30. 2007
    ..In contrast, intracoronary infusion of bone marrow cells appears to improve ejection fraction. We aimed to evaluate the G-CSF mobilization of subsets of stem cells...
  8. ncbi Circulating angiogenic cytokines and stem cells in patients with severe chronic ischemic heart disease--indicators of myocardial ischemic burden?
    Rasmus Sejersten Ripa
    Cardiac Catheterization Laboratory, University Hospital Rigshospitalet, Copenhagen, Denmark
    Int J Cardiol 120:181-7. 2007
    ....
  9. ncbi G-CSF therapy with mobilization of bone marrow stem cells for myocardial recovery after acute myocardial infarction--a relevant treatment?
    Rasmus Sejersten Ripa
    Department of Cardiology, The Heart Centre, Rigshospitalet, Copenhagen University Hospital, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
    Exp Hematol 36:681-6. 2008
    ..Cell-based therapies to improve cardiac function remain promising and further experimental and clinical studies are warranted to determine the future role of G-CSF...
  10. ncbi Myocardial regeneration induced by granulocyte-colony-stimulating factor mobilization of stem cells in patients with acute or chronic ischaemic heart disease: a non-invasive alternative for clinical stem cell therapy?
    Jens Kastrup
    Department of Cardiology, The Heart Centre, University Hospital Rigshospitalet, Copenhagen, Denmark
    Eur Heart J 27:2748-54. 2006
    ....
  11. ncbi Association between lectin complement pathway initiators, C-reactive protein and left ventricular remodeling in myocardial infarction-a magnetic resonance study
    Mikkel Malby Schoos
    Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Denmark
    Mol Immunol 54:408-14. 2013
    ..Also, C-reactive protein (CRP) and ficolin-2 interact in vitro, but the role of the ficolins in IRI is unknown...